<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">

<html>
<head>
	
	<title>Colgate Review </title>

</head>

<body>
<HTML>
<HEAD>
<TITLE></TITLE>


<FONT FACE="Bold" SIZE="5" >


Review of FDA Position on Stannous Fluoride and CPC</br>Prepared for Dr. Anthony Volpe (5/06)</a></p>








<FONT FACE="Arial" SIZE="3" COLOR="#FF0000">
<b>FDA Proposed Rule for OTC Antigingivitis/Antiplaque Products: <br>
<b>Oral Health Care Drug Products for Over-the-Counter Human Use; <br> Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph; Proposed Rules (5/2003)</b></p>

<FONT FACE="Arial" SIZE="2" >

<a href="Colgate/Federal_Register.doc">Federal Register - Color Coded [DOC VERSION]<a><br>
<a href="Colgate/ADA_Response.doc">ADA Response - Color Coded [DOC VERSION]<a><p>


<a href="Colgate/Propose_FDA_Monograph.pdf">Original Copied [PDF VERSION]<a><br>


<a href="http://www.fda.gov/OHRMS/DOCKETS/98fr/03-12783.pdf">Original [INTERNET PDF VERSION]<a><p>
<a href="Colgate/05-12748.doc">2005 FDA Position [DOC VERSION]<a><p>


<FONT FACE="Arial" SIZE="3" COLOR="#FF0000">
<b>MISCELLANEOUS FDA Reactions to Stannous Fluoride or CPC</a></p>
<FONT FACE="Arial" SIZE="2" >
<a href="Colgate/FDA_Letter_SinoFresh.doc">1) FDA Letter SinoFresh 0.05%CPC for nasal cilia and mucosa [DOC VERSION]</a></br>


<a href="http://www.fda.gov/foi/warning_letters/g5070d.htm">2) OmniiGel is not entitled to bear the “Rx only” legend because it can be marketed as an OTC drug (WARNING LETTER)[INTERNET PDF  VERSION]</a></br>
<a href="http://a257.g.akamaitech.net/7/257/2422/04nov20031500/edocket.access.gpo.gov/cfr_2001/aprqtr/21cfr355.10.htm
">3) ANTICARIES DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE--Table of Contents
Subpart B--Active Ingredients  Sec. 355.10  Anticaries active ingredients
(INCLUDES STANNOUS FLUORIDE LEVELS)[INTERNET PDF  VERSION]</a></br>
<a href="http://www.cfsan.fda.gov/~lrd/fr040402.html">4) Approved use of CPC as antimicrobial agent in poultry processing
[INTERNET PDF  VERSION]</a></br>

<a href="http://www.fda.gov/ohrms/dockets/dailys/03/Nov03/112803/81n-0033p-c000014-025-Labeling-Indications-Warning-vol81.pdf">
5) P&G RECOMMENDATIONS RELATED BY FDA for LABELLING OF OTC SnF2 and CPC Products [INTERNET PDF  VERSION]</a></p>










<FONT FACE="Arial" SIZE="3" COLOR="#FF0000">
<b>FDA Proposed Guidelines for the Design of Clinical Trials to test AntiGingivitis/AntiPlaque Agents(6/2005)]</a></p>






<FONT FACE="Arial" SIZE="2" >
<a href="http://www.fda.gov/cder/guidance/5146dft.htm">Guidance for Industry
Gingivitis: Development and Evaluation of Drugs for Treatment or Prevention(6/05) [INTERNET PDF VERSION]</a></p>

________________________________________</a></p>
ADVICE on Returning from documents:</a></br>
For [DOC VERSION].... Go to GOTO in Toolbar and Pull Down/Select BACK</a></br>
For [INTERNET PDF VERSION].... Click Go to VIEW in Toolbar and Pull Down/Select BACK</a></br>

</body>
</html>

